What is toxicology and how does toxicity occur?

Best Practice and Research: Clinical Anaesthesiology

Volumn 17, Issue 1, 2003, Pages 5-27

  Mückter, Harald ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

Drug host interactions; Toxicodynamics; Toxicogenetics; Toxicokinetics

Indexed keywords

ALLOPURINOL; ANTIDEPRESSANT AGENT; ANTIINFECTIVE AGENT; ANTINEOPLASTIC AGENT; AZATHIOPRINE; CAPTOPRIL; CARBON TETRACHLORIDE; CELL PROTEIN; CHLORPROMAZINE; CYCLOSPORIN; DIAZEPAM; GLUCOCORTICOID; GOLD; HISTAMINE H1 RECEPTOR ANTAGONIST; ISONIAZID; LITHIUM; METHOTREXATE; NITROFURANTOIN; NONSTEROID ANTIINFLAMMATORY AGENT; OMEPRAZOLE; ORAL CONTRACEPTIVE AGENT; PHENYTOIN; PROTEOME; SEROTONIN UPTAKE INHIBITOR; SULFONAMIDE; TETRACYCLINE; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG; VALPROIC ACID; XENOBIOTIC AGENT;

ARTICLE; BILE DUCT DISEASE; CENTRAL NERVOUS SYSTEM DISEASE; CHEMICAL INTERACTION; CHOLANGITIS; CHOLESTASIS; DNA POLYMORPHISM; DRUG INTOXICATION; DRUG PROTEIN BINDING; ECOSYSTEM; ELECTROLYTE DISTURBANCE; ENVIRONMENTAL EXPOSURE; GENE MUTATION; GENETIC TOXICOLOGY; HUMAN; HYPERPYREXIA; HYPOGLYCEMIA; HYPONATREMIA; HYPOXIA; IMMUNE RESPONSE; INAPPROPRIATE VASOPRESSIN SECRETION; INTRAOCULAR HYPERTENSION; LIVER NECROSIS; LIVER TOXICITY; MICROANGIOPATHY; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; SEIZURE; SIDE EFFECT; STEATOSIS; STRUCTURE ACTIVITY RELATION; TOXIC HEPATITIS; TOXICOLOGY; URINARY TRACT DISEASE; URINE OSMOLALITY; VASCULAR DISEASE; WATER RETENTION; ABSORPTION; ANIMAL; BIOLOGICAL MODEL; CELL NUCLEUS; DRUG EFFECT; MITOCHONDRION; PHARMACOKINETICS; QUANTITATIVE STRUCTURE ACTIVITY RELATION; REVIEW; TISSUE DISTRIBUTION;

ABSORPTION; ANIMALS; CELL NUCLEUS; HUMANS; MITOCHONDRIA; MODELS, BIOLOGICAL; PHARMACOKINETICS; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP; TISSUE DISTRIBUTION; TOXICOLOGY;

EID: 0037711250     PISSN: 15216896     EISSN: None     Source Type: Journal    
DOI: 10.1053/bean.2003.0270     Document Type: Article

References (44)

1. Klaassen C D Principles of toxicology and treatment of poisoning In Hardman J D Limbird & L E Goodman-Gilman A (eds.), Goodman & Gilman's The Pharmaceutical Basis of Therapeutics 2001 67-80 McGraw-Hill New York
2. Canyon D Toxic Pollution and Human Health 1999 James Cook University Townsville p. 32
3. Zaccara G Muscas GC Messori A Clinical features, pathogenesis and management of drug-induced seizures Drug Safety 5 1990 109-151
4. Jaechke H Gores GJ Cederbaum AI et al. Mechanisms of hepatotoxicity Toxicological Science 65 2002 166-176
5. Bourdi M Masubuchi Y Reilly TP et al. Protection against acetaminophen-induced liver injury and lethality by interleukin 10: role of inducible nitric oxide synthase Hepatology 35 2002 289-298
6. Maesaka J K An expanded view of SIADH, hyponatremia and hypouricemia Clinical Nephrology 46 1996 79-83
7. Weiss S M Lakshminarayan S Acute inhalation injury Clinical Chest Medicine 15 1994 103-116
8. Welty-Wolf KE Carraway MS Idell S et al. Tissue factor in experimental acute lung injury Seminars in Hematology 38 2001 35-38 4 Supplement 12
9. Eisenman A Armali Z Raikhlin-Eisenkraft B et al. Nitric oxide inhalation for paraquat-induced lung injury Journal of Toxicology and Clinical Toxicology 36 1998 575-584
10. Reigart JR Roberts JR (Eds.) Recognition and Management of Pesticide Poisonings 5th edn. 1999 Office of Pesticide Programs Arlington
11. Curry SC Chang D Connor D Drug- and toxin-induced rhabdomyolysis Annals of Emergency Medicine 18 1989 1068-1084
12. Predergast BD George CF Drug-induced rhabdomyolysis-mechanisms and management Postgraduate Medical Journal 69 1993 333-336
13. Omar MA Wilson JP Cox TS Rhabdomyolysis and HMG-CoA reductase inhibitors Annals of Pharmacotherapy 35 2001 1096-1107
14. Kumar D McAlister F A Rhabdomyolysis complicating unrecognized hypophosphatemia in an alcoholic patient Canadian Journal of Gastroenterology 13 1999 165-167
15. Roberts RA Nebert DW Hickman JA et al. Perturbation of the mitosis/apoptosis balance: a fundamental mechanism in toxicology Fundamental and Applied Toxicology 38 1997 107-115
16. Bittar EE Bittar N (Eds.) Cell Injury 1998 Elsevier Science Amsterdam
17. Ruvolo PP Deng X May WS Phosphorylation of Bcl2 and regulation of apoptosis Leukemia 15 2001 515-522
18. Ameral-Mendes JJ The endocrine disrupters: a major medical challenge Food and Chemical Toxicology 40 2002 781-788
19. Walker U A Clinical manifestations of mitochondrial toxicity Journal of HIV Therapy 6 2001 17-21
20. Vamecq J Valée L Latruffe N Peroxisomes and PPARs: a key role in metabolism and cell differentiation In Eaton S & Quant PA (Eds.) New Avenues of Research Fatty Acid Oxidation and Ketone Body Metabolism 2001 63-69 FAOXK Press London
21. Cavallini L Francesconi M A Zoccarto F Alexandre A Involvement of nuclear factor-kappa B (NF-kappaB) activation in mitogen-induced lymphocyte proliferation: inhibitory effects of lymphoproliferation by salicylates acting as NF-kappaB inhibitors Biochemical Pharmacology 62 2001 141-147
22. Cai W Hu L Foulkes J G Transcription-modulating drugs: mechanism and selectivity Current Opinion in Biotechnology 7 1996 608-615
23. Blendy J A Maldonado R Genetic analysis of drug addiction: the role of cAMP response element binding protein Journal of Molecular Medicine 76 1998 104-110
24. Carlezon WA Jr. Thome J Olslon VG et al. Regulation of cocaine reward by CREB Science 282 1998 2272-2275
25. Grove J Daly AK Bassendine MF et al. Interleukin 10 promoter region polymorphisms and susceptibility to advanced alcoholic liver disease Gut 46 2000 540-545
26. 2+ regulation defects Physiology Reviews 76 1996 537-592
27. + regulation Bioscience Reports 21 2001 155-168
28. Meltzer PS Spotting the target: microarrays for disease gene discovery Current Opinion in Genetic Development 11 2001 258-263
29. Celis J E Kruhoffer M Gromova I et al. Gene expression profiling: monitoring transcription and translation products using DNA microarrays and proteomics FEBS Letters 480 2000 2-16
30. Eggleston PA Buckley TJ Breysse PN et al. The environment and asthma in U.S. inner cities Environmental Health Perspectives 107 supplement 3 1999 439-450
31. Alberts B Johnson A Lewis J (eds) Molecular Biology of the Cell 2002 Garland Publisher New York
32. Lewis DFV Guide to Cytochromes P450: Structure & Function 2001 Taylor & Francis London
33. Hu KT Matayoshi A Stevenson FT Calculation of the estimated creatinine clearance in avoiding drug dosing errors in the older patient American Journal of Medical Science 322 2001 133-136
34. Wright JG Boddy AV Highley M et al. Estimation of glomerular filtration rate in cancer patients British Journal of Cancer 84 2001 452-459
35. Tzamaloukas AH Murata GH Creatinine excretion in continuous peritoneal dialysis: a systematic error of the Cockroft-Gault formula American Journal of Kidney Disease 38 2001 862-866
36. Skatrud P L The impact of multiple drug resistance (MDR) proteins on chemotherapy and drug discovery Progress in Drug Research 58 2002 99-131
37. Leslie EM Deeley RG Cole SP Toxicological relevance of the multidrug resistance protein 1, MRP1 (ABCC1) and related transporters Toxicology 167 2001 3-23
38. Phillips JC Gibson WB Yam J et al. Survey of the QSAR and in vitro approaches for developing non-animal methods to supersede the in vivo LD50 test Food and Chemical Toxicology 28 1990 375-394
39. Soffers AE Boersma MG Vaes WH et al. Computer-modeling-based QSARs for analyzing experimental data on biotransformation and toxicity Toxicology In Vitro 15 2001 539-551
40. Tropsha A Zheng W Identification of the descriptor pharmacophores using variable selection QSAR: applications to database mining Current Pharmacological Design 7 2001 599-612
41. Thummel KE Shen DD (Eds) Design and optimization of dosage regimens: pharmacokinetic data In Hardman JD Limbird LE & Goodman-Gilman A (eds.), Goodman & Gilman's The Pharmaceutical Basis of Therapeutics 2001 1917-2023 McGraw-Hill New York
42. Eichelbaum M Schwab M (Eds) Wirkungen des organismus auf pharmaka: allgemine pharmakokinetik In Forth W Henschler D Rummel W Förstermann U & Starke K (eds.), Allgemeine und spezielle Pharmakologie und Toxikologie 2001 39-52 Urban & Fischer München
43. Manjunath G Sarnak MJ Levey AS Estimating the glomerular filtration rate. Do's and don'ts for assessing kidney function Postgraduate Medicine 110 2001 55-62
44. Gut J Christen U Huwyler J Mechanisms of halothane toxicity: novel insights Pharmacology and Therapeutics 58 1993 133-155